Am I wrong for using my own medical license to override my niece’s insurance denial?
I (45F) am my niece’s pediatric oncologist. She’s seven. She has maybe four months without this treatment.
Emma’s been my patient for two years, since the first diagnosis. My sister Kristen and her husband Doug trust me completely with her care, or at least they used to. When the leukemia came back last month, I put in for a CAR-T therapy that’s her best shot. The insurance company denied it three times. Called it “not medically necessary.”
I sat at Kristen’s kitchen table last Tuesday going through the denial letter line by line. That’s when Doug’s brother Randy showed up, the one who works “in insurance” and loves telling people how the system actually works.
Randy looked at the letter, looked at me, and said, “Honestly? Sounds like the doctors are pushing treatments that aren’t proven. Insurance companies aren’t always wrong, you know.”
I told him I AM the doctor. I wrote the treatment plan.
He shrugged and said, “Doesn’t mean you’re not too close to this to see it clearly.”
So I did something I’ve never done in eighteen years of practicing medicine. I called in a favor from a colleague on the insurance company’s own physician review board, someone who owes me from residency, and asked her to personally reexamine Emma’s file outside the normal channel. Kristen found out an hour later and lost it, screaming that I was going to get my license pulled over her daughter, that I should have let the appeals process play out.
Doug just stood there in the doorway, not saying anything.
Then my phone rang. Unknown number, area code from the insurance company’s headquarters. I stepped into the hallway to answer it, and the woman on the other end said, “I need to ask you something first, before we talk about the appeal – – did Randy Kowalski already file a complaint?”
I stopped with my shoulder against the hallway wall. The wallpaper was the same dusty rose Kristen picked out when she was pregnant with Emma, the one I helped her hang seven years ago, before any of us knew what CD19-negative meant.
“Elise,” I said. “What kind of complaint?”
“Anonymous. Landed in my inbox twenty minutes ago. Accuses the treating physician of manipulating the peer-review process through personal relationships. They name you. They name me.” Dr. Elise O’Neill and I did our fellowship together at St. Jude’s. She owes me for covering twenty-six of her on-call nights when her mother was dying. I’ve never asked for anything until yesterday. “Tell me you didn’t talk to anyone about this.”
I looked toward the kitchen. Through the doorway I could see Kristen at the table, her face in her hands. Doug hadn’t moved. Randy was scrolling his phone, leaning against the counter like he was waiting for a bus.
“Randy,” I said.
“Your brother-in-law Randy.”
“Doug’s brother. He’s – he works in insurance. He was here when I told them.”
A pause. I heard Elise typing. “He listed the patient’s name and date of birth. That’s a HIPAA-adjacent mess if anyone traces it back to you discussing the case in his presence. Did he hear you mention my name?”
“I don’t think so. I just said I’d call in a favor. He’s the kind of guy who – ” I stopped. Randy was the kind of guy who wore pleated khakis to backyard barbecues and used phrases like “fiduciary responsibility” while flipping burgers. “He thinks he’s helping.”
“He’s not.” Elise’s voice dropped. “The complaint triggered an automatic flag on the appeal. They’ve frozen the case pending an internal review. Standard protocol. Three weeks minimum.”
“Emma doesn’t have three weeks.”
“I know. That’s why I’m calling from my personal phone. This isn’t official.”
I pressed my palm flat against the wallpaper. The seam where Kristen and I had mismatched the pattern by a quarter inch was still there. I’d laughed about it then. You’re a doctor, she’d said, not a decorator. Just keep my kid alive, okay?
She’d been kidding. She’d been three months pregnant and joking about mortality.
How We Got Here
Emma was diagnosed at five. B-cell ALL. Standard risk, the kind the textbooks call “a good cancer to have if you have to have cancer.” Which is a phrase I have never once uttered in front of a parent, because there is no good cancer for a five-year-old.
I wasn’t supposed to be her oncologist. The hospital has rules about treating family, soft guidelines about objectivity and emotional distance. But Kristen asked. She sat in my office with her hands folded in her lap like she was eight years old again, the year our father died, and she said, “I know you’re the best one in that building. I know it. And I’m asking you to be the one.”
I cleared it with my department head. I cleared it with the ethics committee. I signed paperwork that said I understood the risks of dual relationships and accepted full responsibility.
Two years of chemotherapy. Two years of Emma losing her hair and growing it back and losing it again. Two years of port infections and mouth sores and the day her ANC hit zero and we sat in the isolation room watching Frozen on a tablet because she couldn’t leave the bed. She asked me if Elsa had cancer and I said no, Elsa just had ice powers. She said, “Good. Cancer is dumb.”
She was five. She was right.
The remission lasted eleven months. I found the relapse myself, on a routine follow-up blood draw. The lymphoblasts were back, higher than before, CD19-negative this time, which meant the standard CAR-T that had just been FDA-approved wouldn’t work. There was a newer construct, a trial-adjacent protocol using CD22-targeted cells, still under review but with early data that made me want to weep. I’d seen the results out of Philadelphia. I knew the principal investigator. I wrote the treatment plan the same night I got the labs back, sitting at my kitchen counter at two in the morning, because if I waited for the insurance company’s prior authorization process to crawl through their evidence review, Emma would be dead before they finished the first page of the denial.
They denied it anyway.
“Not medically necessary” is insurance-speak for “we don’t want to pay for this because the data set is still under 200 patients and the lifetime cost is north of half a million dollars.” It has nothing to do with medicine. It’s actuarial math with a veneer of clinical language. I explained this to Kristen and Doug three separate times. And then Randy showed up.
The Kitchen Table
Randy works for a mid-level carrier two states over, processing claims for outpatient physical therapy. He has no oncology background. He has no clinical training. What he has is a LinkedIn profile that says “Healthcare Policy Analyst” and an unshakeable conviction that he understands the system better than anyone in the room.
“This isn’t personal,” he said, tapping the denial letter with his index finger. The nail was too clean, the kind you get from a professional manicure. “The clinical evidence just isn’t there yet. I’ve seen this a hundred times. Doctors get attached to experimental treatments because they want to believe, but the actuaries are looking at population-level outcomes, not individual cases. You’re too close.”
“I’m her doctor.”
“And her aunt.”
“Yes. Both. Which means I know her antigen markers and I know that she can’t keep down applesauce and I know that the CD22 construct has a seventy-two percent response rate in her specific disease subtype because I read the goddamn papers, Randy.”
He didn’t flinch. That’s what got me. He didn’t even blink.
“Seventy-two percent in a sample size of eighty-seven patients observed over eighteen months,” he said. “That’s not statistically robust enough for formulary inclusion. The denial is procedurally sound.”
Kristen was watching me. Her eyes had that glassy look she gets when she’s trying to figure out whether to be furious or terrified.
“Randy,” I said, “do you know what happens if we wait for the evidence base to mature? Emma’s bone marrow crosses a blast threshold that the CAR-T can’t rescue. She dies. Probably around Christmas.”
That’s when I made the call to Elise. Right there, in front of all of them, not even thinking about the optics.
Kristen found out what I’d done an hour later because Elise called back to confirm she’d received the file, and Kristen grabbed my phone off the counter. She read the name on the screen. She put it together faster than I expected.
“You asked someone on their review board?” Her voice went high and thin. “You used a backchannel? You’re going to lose your license. You’re going to lose your license over my daughter and then what happens to her if you’re not even allowed to practice – “
“That won’t happen.”
“You don’t know that.”
“I know Elise. I know what she’s risking. She wouldn’t do it if she thought – “
“She’s doing it because she owes you. That’s the definition of a conflict of interest.”
Doug, in the doorway: still silent. Doug’s silence is a whole language. I’ve known him for fifteen years and I can read every dialect. This one was disappointment mixed with something worse, something that looked like he was already grieving two people instead of one.
Then my phone rang again. Unknown number. The insurance company’s area code.
The Call
Elise was quiet for a long moment after she told me about the flagged case.
“Okay,” I said. “How do I fix it?”
“You can’t. You withdraw the request for external review, you let the standard appeals process run, and in three weeks maybe they overturn it maybe they don’t. If you push now you’re going to trigger a formal investigation and I’m going to lose my position on the board. Best case. Worst case they refer you to the state medical board for ethical violations.”
“And Emma?”
Another pause. I could hear her breathing. We’d stood next to each other in the PICU at two in the morning so many times, watching monitors, waiting for fevers to break. She knew what I was asking.
“If it were my kid,” she said, “I’d figure out another way.”
The line went dead. I stared at the wallpaper seam, that quarter-inch of misalignment that I’d told Kristen we could fix with a little spackle and she’d said, don’t bother, it gives the room character.
Another Way
I’m on staff at Children’s. I have admitting privileges. And I know – I have always known, filed away in the back of my head like the combination to a safe I hoped I’d never have to open – that the hospital’s pharmacy carries the viral vector for the CD22 CAR-T construct under a shared manufacturing agreement with the trial site in Philadelphia. It’s physically there, in our clean room, because we’re one of the enrollment centers for the Phase II trial that Emma doesn’t technically qualify for because the inclusion criteria require two prior lines of therapy and she’s only had one.
But there’s a compassionate-use pathway. Single-patient IND. Emergency authorization for life-threatening conditions when no comparable alternative exists. It requires a physician’s attestation that the patient will die without the intervention and that the potential benefit justifies the risk. It bypasses insurance review entirely. The hospital absorbs the cost. Administration hates it. Legal reviews it. But it’s legal.
It also requires that I, as the requesting physician, certify that I am not acting under any conflict of interest that might impair my medical judgment.
I drove to the hospital. It was 4:47 p.m. on a Tuesday. The parking garage was half-empty. I sat in my car with the engine off and filled out Form FDA 3926 on my phone while my hands shook so badly I had to retype Emma’s date of birth four times.
The form asks: What is your relationship to the patient?
I typed: Maternal aunt. Also treating oncologist.
The form asks: Describe alternative treatments considered and why they are inadequate.
I typed: Patient has CD19-negative relapsed/refractory B-ALL. Standard salvage chemotherapy offers <10% event-free survival at 12 months. CD22-targeted CAR-T has demonstrated 72% overall response rate in comparable patient population (Maude et al., 2022). Without intervention, median survival is estimated at 4 months.
The form asks: Certify that you have no financial or personal interest that might compromise the objectivity of this request.
My thumb hovered over the checkbox.
If I checked it, I was lying on a federal form. If I didn’t check it, the request would be rejected for conflict of interest and Emma would die while we waited for the insurance company’s internal review to conclude that Randy Kowalski’s anonymous tip merited further investigation.
I checked it.
I lied on a federal form and I submitted it and I called the oncology pharmacist on her personal cell and I said, “Denise, I need the lot number for the CD22 construct we have in cold storage. I’m submitting a single-patient IND for my niece.”
Denise was quiet for a beat. “You’re her physician of record.”
“Yes.”
“You know this is going to be flagged.”
“I know.”
“Your department head is going to see it. The FDA is going to see it. The IRB chair – “
“I know, Denise. Lot number. Please.”
She gave it to me. I wrote it on a napkin from the glove compartment, a napkin that had been sitting there since I bought the car, from a coffee shop that closed two years ago.
Starting the Drip
Emma was admitted at 7:22 p.m.
I didn’t call Kristen. I didn’t call Doug. I texted them the room number and wrote: She’s getting the treatment. Come to the hospital. I’ll explain everything.
They arrived six minutes later. Kristen’s face was blotchy, the way it gets when she’s been crying in the car. Doug was carrying Emma’s stuffed octopus, the one with the missing tentacle that she refuses to let anyone sew back on because she says it “gives him personality.”
“What did you do,” Kristen said. Not a question.
I told them. I told them about compassionate use and single-patient INDs and the certification I’d falsified and the review board complaint that was going to land on my boss’s desk within forty-eight hours. Doug sat down heavily in the visitor chair, the octopus dangling from his hand.
Kristen said, “They’re going to take your license.”
“Maybe.”
“They’re going to take your license and it’s my fault because I asked you to be her doctor and I – “
“No.” I said it louder than I meant to. A nurse glanced in from the hallway. “It’s not your fault. It’s not anybody’s fault. A system that lets a man in khakis decide whether a seven-year-old gets to live or die based on sample-size concerns is the thing that’s at fault. I made a choice. I’d make it again.”
“I called Elise back,” Kristen whispered. “After you left. She told me about the complaint. She told me what Randy did.”
“Randy can go to hell.”
“Yeah.” Kristen’s mouth did something that was almost a smile. “I already told him that. He left.”
Doug, still in the chair: “Is it going to work?”
I looked at Emma’s port, already accessed, the clear tubing snaking up to the IV pole. The bag was labeled with a pharmacy sticker: AUTOLOGOUS CD22-CAR T-CELLS. PATIENT: EMMA R. DOB: 03/14/2017.
“I believe it will. The Philadelphia data is strong. And her disease burden isn’t high enough yet to cause severe CRS. We’re catching it before the blast crisis.”
“That’s not what I meant.” Doug’s voice was sandpaper. “Are you going to lose your license?”
I didn’t answer. I couldn’t. Because the truth was I didn’t know, and the not-knowing was a cold, sharp thing lodged in my chest, right next to the certainty that I would do it again, every time, forever, for any kid who walked through those doors.
The nurse hung the bag. The pump beeped twice and started. The fluid moved through the line, clear as water, full of reprogrammed cells that I had lied on a federal document to obtain. Emma was asleep, her small face slack, her hand curled on the pillow.
I watched the drip chamber. One drop. Another. Another.
Kristen reached over and grabbed my hand. Her fingers were cold. Neither of us said anything.
The machine beeped again, adjusting the rate, and outside the window the sky was doing that thing it does in October when the light goes orange and then purple and then just gone, and Emma’s monitor traced her heartbeat in steady green lines, and I stood there in the half-dark counting the drops and waiting for the phone to ring.
If you’re dealing with difficult family situations, you might find some solidarity in reading about My Six-Year-Old Drew a Man Climbing Through Our Window, and Called Him “Mommy’s Friend” or even I Have Fourteen Children’s Names Here. For more intense ethical dilemmas, consider this story about My Partner Turned Down Her Ex-Husband’s IV During a Trauma Code.
